Charles W. Newhall III, Director, 10% Owner at SUPERNUS PHARMACEUTICALS INC (SUPN), bought 10,641,250 shares at $5.00 ($22.0M) on 2012-05-04, disclosed to the SEC on 2012-05-08.
Open-market purchase of $22.0M SUPN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,241,250 | $0 | 0.0% |
| 2 | $5.00 | 4,400,000 | $22.0M | 100.0% |
| Total | $2.07 avg | 10,641,250 | $22.0M | 100% |
| Filing → |
| SUPN | SELL | 2025-08-27 | $45K | — | Filing → |
| SUPN | SELL | 2025-08-26 | $64K | — | Filing → |
| SUPN | SELL | 2024-11-12 | $388K | — | Filing → |